rs146696590
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 3P and 7B. PM2PP3BP4_ModerateBP6BS1
The NM_001080476.3(GRXCR1):c.785G>A(p.Arg262Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000679 in 1,613,960 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R262L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001080476.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRXCR1 | NM_001080476.3 | c.785G>A | p.Arg262Gln | missense_variant | 4/4 | ENST00000399770.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRXCR1 | ENST00000399770.3 | c.785G>A | p.Arg262Gln | missense_variant | 4/4 | 1 | NM_001080476.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000612 AC: 93AN: 151992Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000713 AC: 178AN: 249478Hom.: 0 AF XY: 0.000650 AC XY: 88AN XY: 135350
GnomAD4 exome AF: 0.000686 AC: 1003AN: 1461850Hom.: 0 Cov.: 31 AF XY: 0.000638 AC XY: 464AN XY: 727228
GnomAD4 genome AF: 0.000611 AC: 93AN: 152110Hom.: 1 Cov.: 32 AF XY: 0.000538 AC XY: 40AN XY: 74356
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 01, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 24, 2017 | The p.Arg262Gln variant in GRXCR1 has been identified by our laboratory in 2 ind ividuals with hearing loss; however a second variant was not identified in eithe r individual. The variant has also been identified in 0.4% (36/10150) of Ashkena zi Jewish and 0.1% (102/126588) of European chromosomes by the Genome Aggregatio n Database (gnomAD, http://gnomad.broadinstitute.org/; rs146696590) and has been reported in ClinVar (Variation ID: 228734); however its frequency is not high e nough to rule out a pathogenic role. Computational prediction tools and conserva tion analysis suggest the variant may impact the protein; however this data is i nsufficient to assume pathogenicity. In summary, the clinical significance of th e p.Arg262Gln variant is uncertain. - |
Autosomal recessive nonsyndromic hearing loss 25 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
GRXCR1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at